Bio-Rad Laboratories EBITDA 2010-2025 | BIO
Bio-Rad Laboratories annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Bio-Rad Laboratories EBITDA for the quarter ending March 31, 2025 was $0.024B, a 46.86% decline year-over-year.
- Bio-Rad Laboratories EBITDA for the twelve months ending March 31, 2025 was $0.248B, a 22.59% decline year-over-year.
- Bio-Rad Laboratories 2024 annual EBITDA was $0.269B, a 20.37% decline from 2023.
- Bio-Rad Laboratories 2023 annual EBITDA was $0.338B, a 30% decline from 2022.
- Bio-Rad Laboratories 2022 annual EBITDA was $0.483B, a 3.54% decline from 2021.
| Bio-Rad Laboratories Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $269 |
| 2023 | $338 |
| 2022 | $483 |
| 2021 | $500 |
| 2020 | $421 |
| 2019 | $230 |
| 2018 | $-103 |
| 2017 | $119 |
| 2016 | $56 |
| 2015 | $167 |
| 2014 | $150 |
| 2013 | $169 |
| 2012 | $264 |
| 2011 | $305 |
| 2010 | $284 |
| 2009 | $231 |
| Bio-Rad Laboratories Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $24 |
| 2024-12-31 | $58 |
| 2024-09-30 | $64 |
| 2024-06-30 | $101 |
| 2024-03-31 | $45 |
| 2023-12-31 | $95 |
| 2023-09-30 | $91 |
| 2023-06-30 | $90 |
| 2023-03-31 | $62 |
| 2022-12-31 | $119 |
| 2022-09-30 | $95 |
| 2022-06-30 | $123 |
| 2022-03-31 | $146 |
| 2021-12-31 | $118 |
| 2021-09-30 | $157 |
| 2021-06-30 | $125 |
| 2021-03-31 | $101 |
| 2020-12-31 | $186 |
| 2020-09-30 | $110 |
| 2020-06-30 | $52 |
| 2020-03-31 | $74 |
| 2019-12-31 | $59 |
| 2019-09-30 | $57 |
| 2019-06-30 | $56 |
| 2019-03-31 | $57 |
| 2018-12-31 | $-227 |
| 2018-09-30 | $71 |
| 2018-06-30 | $44 |
| 2018-03-31 | $44 |
| 2017-12-31 | $56 |
| 2017-09-30 | $74 |
| 2017-06-30 | $35 |
| 2017-03-31 | $60 |
| 2016-12-31 | $-21 |
| 2016-09-30 | $67 |
| 2016-06-30 | $60 |
| 2016-03-31 | $60 |
| 2015-12-31 | $59 |
| 2015-09-30 | $33 |
| 2015-06-30 | $40 |
| 2015-03-31 | $34 |
| 2014-12-31 | $51 |
| 2014-09-30 | $33 |
| 2014-06-30 | $46 |
| 2014-03-31 | $20 |
| 2013-12-31 | $52 |
| 2013-09-30 | $29 |
| 2013-06-30 | $53 |
| 2013-03-31 | $35 |
| 2012-12-31 | $71 |
| 2012-09-30 | $66 |
| 2012-06-30 | $73 |
| 2012-03-31 | $54 |
| 2011-12-31 | $96 |
| 2011-09-30 | $74 |
| 2011-06-30 | $68 |
| 2011-03-31 | $67 |
| 2010-12-31 | $78 |
| 2010-09-30 | $75 |
| 2010-06-30 | $68 |
| 2010-03-31 | $63 |
| 2009-12-31 | $56 |
| 2009-09-30 | $67 |
| 2009-06-30 | $56 |
| 2009-03-31 | $51 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.567B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $236.635B | 28.45 |
| Boston Scientific (BSX) | United States | $158.907B | 39.78 |
| Stryker (SYK) | United States | $151.008B | 31.58 |
| EssilorLuxottica (ESLOY) | France | $127.124B | 0.00 |
| Medtronic (MDT) | Ireland | $111.799B | 15.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.541B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.605B | 26.59 |
| ResMed (RMD) | United States | $37.830B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $33.916B | 16.10 |
| Agilent Technologies (A) | United States | $33.522B | 21.85 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Koninklijke Philips (PHG) | Netherlands | $23.091B | 16.20 |
| Insulet (PODD) | United States | $22.110B | 86.79 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.046B | 11.59 |
| Baxter (BAX) | United States | $15.539B | 11.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.415B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.664B | 14.29 |
| Prestige Consumer Healthcare (PBH) | United States | $3.946B | 17.63 |
| Perrigo (PRGO) | Ireland | $3.673B | 9.31 |
| Haemonetics (HAE) | United States | $3.584B | 16.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.312B | 27.52 |
| ICU Medical (ICUI) | United States | $3.252B | 23.98 |
| QuidelOrtho (QDEL) | United States | $1.949B | 13.40 |
| LeMaitre Vascular (LMAT) | United States | $1.876B | 41.94 |
| AtriCure (ATRC) | United States | $1.622B | 0.00 |
| Acuren (TIC) | United States | $1.341B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.273B | 12.92 |
| Green Thumb Industries (GTBIF) | United States | $1.167B | 26.24 |
| Neogen (NEOG) | United States | $1.037B | 13.28 |
| Phibro Animal Health (PAHC) | United States | $1.035B | 13.23 |
| BioLife Solutions (BLFS) | United States | $1.023B | 0.00 |
| InMode (INMD) | Israel | $0.913B | 9.20 |
| Kestra Medical Technologies (KMTS) | United States | $0.851B | 0.00 |
| Owens & Minor (OMI) | United States | $0.703B | 5.83 |
| CeriBell (CBLL) | United States | $0.677B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.559B | 0.00 |
| Valneva SE (VALN) | France | $0.482B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.454B | 0.00 |
| Surmodics (SRDX) | United States | $0.425B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.417B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.357B | 13.14 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| ZimVie (ZIMV) | United States | $0.260B | 11.84 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.252B | 0.00 |
| Brainsway (BWAY) | Israel | $0.248B | 65.75 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 70.67 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| TriSalus Life Sciences (TLSI) | United States | $0.206B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.06 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.05 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 11.97 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.080B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| MacroGenics (MGNX) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.063B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.43 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.70 |
| Rockwell Medical (RMTI) | United States | $0.029B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |